Home/Filings/4/0001209191-21-015500
4//SEC Filing

Markels John 4

Accession 0001209191-21-015500

CIK 0001001233other

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 8:59 PM ET

Size

8.5 KB

Accession

0001209191-21-015500

Insider Transaction Report

Form 4
Period: 2021-02-25
Markels John
Director
Transactions
  • Award

    Common Stock

    2021-02-25+8,20013,200 total
  • Award

    Stock Option (Right to Buy)

    2021-02-25+16,40016,400 total
    Exercise: $11.19Exp: 2031-02-24Common Stock (16,400 underlying)
Footnotes (3)
  • [F1]Represents shares of common stock issuable upon settlement of restricted stock units ("RSUs"). The RSUs will fully vest on the first anniversary of the date of grant, subject to the Reporting Person's Continuous Service (as defined in the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the "2018 EIP, as amended")), through such date and subject to acceleration as provided in the 2018 EIP, as amended.
  • [F2]Includes 3,333 shares of common stock issuable upon settlement of RSUs granted to the Reporting Person on February 11, 2020 representing two remaining vesting tranches from such RSU grant. Such RSUs vest with respect to 1,666 shares on February 11, 2022 and 1,667 shares on February 11, 2023, subject to the Reporting Person's Continuous Service Service as defined in the 2018 EIP, as amended, through such dates and subject to acceleration as defined in the 2018 EIP, as amended.
  • [F3]Each option is immediately exercisable for all option shares, but shares purchased under the option are subject to certain repurchase rights by the Issuer upon cessation of the Reporting Person's Continuous Service (as defined in the 2018 EIP, as amended). The shares subject to the option vest in 12 successive equal monthly installments upon the Reporting Person's completion of each month of Continuous Service (as defined in the 2018 EIP, as amended) over the 12-month period measured from the grant date and subject to acceleration as provided in the 2018 EIP, as amended.

Issuer

SANGAMO THERAPEUTICS, INC

CIK 0001001233

Entity typeother

Related Parties

1
  • filerCIK 0001803424

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 8:59 PM ET
Size
8.5 KB